Last reviewed 2026-04-19 · How we verify

Pustular psoriasis

24 treatments

Approved treatments

Cosentyx · Janssen Research & Development, LLC
Sotyktu · Bristol-Myers Squibb
Sotyktu works by blocking the TYK2 enzyme, which is involved in the inflammatory response and contributes to the development of psoriasis.
Spevigo · Boehringer Ingelheim Pharmaceuticals Inc
Spevigo works by blocking the interleukin-36 receptor, which plays a key role in the development of psoriasis symptoms.
Abrilada · AbbVie
Adalimumab-afzb binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors.
Oxarol
Maxacalcitol works by binding to the Vitamin D3 receptor, which helps regulate skin cell growth and differentiation.
Humira · AbbVie
Adalimumab binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors.
Cosentyx · Novartis
Secukinumab selectively binds IL-17A cytokine and inhibits its interaction with IL-17 receptor.
Cimzia · UCB
Certolizumab pegol binds to and neutralizes human TNFα, reducing inflammation without causing antibody-dependent cell-mediated cytotoxicity.
Remicade · Johnson & Johnson
Infliximab binds to TNFα, blocking its interaction with receptors, reducing inflammation and immune responses.
Remicade · Shanghai Biomabs Pharmaceutical Co., Ltd.
Remicade · Johnson & Johnson
Infliximab-dyyb neutralizes TNFα by binding with high affinity to soluble and transmembrane forms, inhibiting receptor binding.
CYLTEZO · BOEHRINGER INGELHEIM
IXIFI · PFIZER INC
Taltz · Yale University
BIMZELX · UCB INC
SPEVIGO · BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Taltz · Eli Lilly
Humanized IgG4 monoclonal antibody that selectively binds IL-17A cytokine and inhibits its interaction with IL-17 receptor.
Skyrizi · AbbVie
Skyrizi works by blocking the interleukin-23 protein, which plays a key role in inflammation and immune response.
Remicade · Johnson & Johnson
Remicade works by binding to and neutralizing tumor necrosis factor, a protein that promotes inflammation and tissue damage.
Bimzelx · Ucb Japan Co., Ltd.
Bimzelx works by binding to interleukin-17A, a protein that promotes inflammation, to reduce symptoms of psoriasis.
Trexall · Generic (originally Lederle Laboratories)
Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune).
Methotrexat · Biocad
Cimzia · University of Washington
Humira · Sohag University

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Pustular psoriasis patent landscape — cliff calendar, originator estates, attackable patents
Pustular psoriasis treatment landscape brief
Pustular psoriasis treatment updates RSS

Frequently asked questions about Pustular psoriasis

What drugs treat Pustular psoriasis?

Tracked treatments include Cosentyx, Sotyktu, Spevigo, Abrilada, Oxarol, Humira, Cimzia, Remicade.

What is the treatment for Pustular psoriasis?

Standard treatment for Pustular psoriasis includes Cosentyx, Sotyktu, Spevigo, Abrilada, Oxarol. See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: Pustular psoriasis patent cliff · Pustular psoriasis CI report
Treatment: Cosentyx · Janssen Research & Development, LLC
Treatment: Sotyktu · Bristol-Myers Squibb
Treatment: Spevigo · Boehringer Ingelheim Pharmaceuticals Inc
Treatment: Abrilada · AbbVie
Treatment: Oxarol
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing